# Percutaneous Endovascular Arch Repair Trial (PEART) Study

> **NCT05872282** · NA · UNKNOWN · sponsor: **Hangzhou Endonom Medtech Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Aortic Diseases

## Interventions

- **DEVICE:** ZIPPER aortic arch stentgraft system

## Key facts

- **NCT ID:** NCT05872282
- **Lead sponsor:** Hangzhou Endonom Medtech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-28
- **Primary completion:** 2025-04-28
- **Final completion:** 2025-04-28
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05872282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05872282, "Percutaneous Endovascular Arch Repair Trial (PEART) Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05872282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*